Medpace (MEDP) Competitors $305.00 -0.28 (-0.09%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$305.10 +0.11 (+0.03%) As of 04/15/2025 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. TCOM, IQV, GIB, CPAY, GFL, RDDT, RBA, AER, KSPI, and ZShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Trip.com Group (TCOM), IQVIA (IQV), CGI (GIB), Corpay (CPAY), GFL Environmental (GFL), Reddit (RDDT), RB Global (RBA), AerCap (AER), Joint Stock Company Kaspi.kz (KSPI), and Zillow Group (Z). These companies are all part of the "business services" industry. Medpace vs. Trip.com Group IQVIA CGI Corpay GFL Environmental Reddit RB Global AerCap Joint Stock Company Kaspi.kz Zillow Group Medpace (NASDAQ:MEDP) and Trip.com Group (NASDAQ:TCOM) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Do insiders and institutionals have more ownership in MEDP or TCOM? 78.0% of Medpace shares are held by institutional investors. Comparatively, 35.4% of Trip.com Group shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 23.0% of Trip.com Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate MEDP or TCOM? Medpace presently has a consensus target price of $357.50, indicating a potential upside of 17.21%. Trip.com Group has a consensus target price of $77.08, indicating a potential upside of 36.50%. Given Trip.com Group's stronger consensus rating and higher possible upside, analysts clearly believe Trip.com Group is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 0 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.31Trip.com Group 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Does the MarketBeat Community favor MEDP or TCOM? Medpace received 252 more outperform votes than Trip.com Group when rated by MarketBeat users. Likewise, 63.15% of users gave Medpace an outperform vote while only 57.06% of users gave Trip.com Group an outperform vote. CompanyUnderperformOutperformMedpaceOutperform Votes35363.15% Underperform Votes20636.85% Trip.com GroupOutperform Votes10157.06% Underperform Votes7642.94% Which has more volatility & risk, MEDP or TCOM? Medpace has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. Comparatively, Trip.com Group has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Which has stronger valuation & earnings, MEDP or TCOM? Trip.com Group has higher revenue and earnings than Medpace. Trip.com Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B4.37$404.39M$12.6324.15Trip.com Group$53.29B0.68$1.40B$3.4916.18 Does the media favor MEDP or TCOM? In the previous week, Medpace had 18 more articles in the media than Trip.com Group. MarketBeat recorded 32 mentions for Medpace and 14 mentions for Trip.com Group. Trip.com Group's average media sentiment score of 1.14 beat Medpace's score of 0.80 indicating that Trip.com Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 16 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Positive Trip.com Group 8 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is MEDP or TCOM more profitable? Trip.com Group has a net margin of 31.86% compared to Medpace's net margin of 19.17%. Medpace's return on equity of 51.48% beat Trip.com Group's return on equity.Company Net Margins Return on Equity Return on Assets Medpace19.17% 51.48% 20.47% Trip.com Group 31.86%12.04%6.70% SummaryMedpace beats Trip.com Group on 10 of the 19 factors compared between the two stocks. Remove Ads Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.22B$3.11B$5.33B$7.57BDividend YieldN/A2.61%5.11%4.32%P/E Ratio24.1582.7521.7317.82Price / Sales4.37120.94379.2094.61Price / Cash24.7234.5738.1534.64Price / Book11.252.326.464.00Net Income$404.39M$118.81M$3.20B$247.23M7 Day Performance0.81%-1.88%2.86%1.45%1 Month Performance-6.14%-17.37%-8.55%-6.24%1 Year Performance-20.79%-12.32%10.47%0.60% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.4319 of 5 stars$305.00-0.1%$357.50+17.2%-21.2%$9.22B$2.11B24.155,900Upcoming EarningsAnalyst DowngradeTCOMTrip.com Group4.7201 of 5 stars$53.55-4.2%$77.08+43.9%+14.8%$34.49B$53.29B16.0336,249Positive NewsGap DownHigh Trading VolumeIQVIQVIA4.9222 of 5 stars$152.72-1.3%$249.05+63.1%-35.5%$26.93B$15.41B20.3686,000Short Interest ↓High Trading VolumeGIBCGI3.5928 of 5 stars$97.23+0.8%$156.75+61.2%+0.3%$22.04B$14.86B17.5890,000Short Interest ↑Positive NewsHigh Trading VolumeCPAYCorpay4.2862 of 5 stars$288.09-0.2%$401.54+39.4%+5.6%$20.24B$3.97B20.6110,500Analyst ForecastPositive NewsGap DownGFLGFL Environmental2.6372 of 5 stars$42.88-4.1%$51.38+19.8%+45.7%$16.87B$7.86B-32.2419,500Short Interest ↑News CoveragePositive NewsGap DownHigh Trading VolumeRDDTReddit3.4126 of 5 stars$92.83+6.8%$162.41+75.0%+140.8%$16.79B$1.30B-12.012,013Analyst ForecastGap DownHigh Trading VolumeRBARB Global3.9877 of 5 stars$90.53-1.4%$107.64+18.9%+33.6%$16.73B$4.28B45.044,200News CoveragePositive NewsGap DownAERAerCap3.7707 of 5 stars$89.52+0.1%$117.43+31.2%+17.2%$16.72B$8.00B7.09740Positive NewsHigh Trading VolumeKSPIJoint Stock Company Kaspi.kz4.2601 of 5 stars$83.28+0.2%$150.67+80.9%-22.5%$16.61B$2.52T8.048,772Upcoming EarningsShort Interest ↓ZZillow Group4.149 of 5 stars$64.08-3.7%$81.71+27.5%+48.5%$15.54B$2.24B-136.345,720News CoveragePositive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Trip.com Group Alternatives IQVIA Alternatives CGI Alternatives Corpay Alternatives GFL Environmental Alternatives Reddit Alternatives RB Global Alternatives AerCap Alternatives Joint Stock Company Kaspi.kz Alternatives Zillow Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDP Stock Free MEDP Stock Alerts